miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases

Oncotarget. 2015 Jun 10;6(16):14153-64. doi: 10.18632/oncotarget.3686.

Abstract

MicroRNAs are involved in the initiation and progression of pancreatic cancer. In this study, we showed that miR-221/222 is overexpressed in pancreatic cancer. MiR-221/222 overexpression significantly promoted pancreatic cancer cell proliferation and invasion while inhibiting apoptosis. The expression of the matrix metalloproteinases (MMPs) MMP-2 and MMP-9 was increased in miR-221/222 mimic-transfected pancreatic cancer cells. Validation experiments identified TIMP-2 as a direct target of miR-221/222. These data indicate that overexpressed miR-221/222 may play an oncogenic role in pancreatic cancer by inducing the expression of MMP-2 and MMP-9, thus leading to cancer cell invasion.

Keywords: matrix metalloproteinases; miR-221/222; pancreatic cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Disease Progression
  • HEK293 Cells
  • Humans
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Matrix Metalloproteinases / metabolism*
  • MicroRNAs / biosynthesis
  • MicroRNAs / genetics*
  • Oncogenes
  • Pancreatic Neoplasms / enzymology*
  • Pancreatic Neoplasms / genetics*
  • Pancreatic Neoplasms / pathology
  • Transfection
  • Up-Regulation

Substances

  • MIRN221 microRNA, human
  • MIRN222 microRNA, human
  • MicroRNAs
  • Matrix Metalloproteinases
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • MMP9 protein, human
  • Matrix Metalloproteinase 9